Page last updated: 2024-08-22

camptothecin and gastrin-releasing peptide

camptothecin has been researched along with gastrin-releasing peptide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aigner, E; Block, NL; Buchholz, S; Datz, C; Hohla, F; Krishan, A; Perez, R; Rick, FG; Schally, AV; Seitz, S; Stadlmayr, A; Szalontay, L	1

Other Studies

1 other study(ies) available for camptothecin and gastrin-releasing peptide

Article	Year
Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers. Cell cycle (Georgetown, Tex.), 2012, Jul-01, Volume: 11, Issue:13 Topics: Animals; Antineoplastic Agents; Bombesin; Camptothecin; Cell Cycle Checkpoints; Cell Line, Tumor; Colonic Neoplasms; Drug Synergism; Drug Therapy, Combination; Fluorouracil; Gastrin-Releasing Peptide; HCT116 Cells; HT29 Cells; Humans; Irinotecan; Male; Mice; Mice, Nude; Peptide Fragments; Receptors, Bombesin; Transplantation, Heterologous	2012

Article

Year

Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers.

Cell cycle (Georgetown, Tex.), 2012, Jul-01, Volume: 11, Issue:13

Topics: Animals; Antineoplastic Agents; Bombesin; Camptothecin; Cell Cycle Checkpoints; Cell Line, Tumor; Colonic Neoplasms; Drug Synergism; Drug Therapy, Combination; Fluorouracil; Gastrin-Releasing Peptide; HCT116 Cells; HT29 Cells; Humans; Irinotecan; Male; Mice; Mice, Nude; Peptide Fragments; Receptors, Bombesin; Transplantation, Heterologous

2012